MENU

XBIO Xenetic Biosciences Forecast, Technical & Fundamental Analysis

a developer of biologic drugs, novel oncology therapeutics, and vaccinations

Industry Biotechnology
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published Earnings

XBIO is expected to report earnings to rise 10.00% to -10 cents per share on May 17

Xenetic Biosciences XBIO Stock Earnings Reports
Q1'23
Est.
$-0.11
Q4'22
Est.
$-0.10
Q3'22
Est.
$-0.06
Q2'22
Est.
$-0.19
Q1'22
Est.
$-0.12
The last earnings report on March 23 showed earnings per share of -10 cents, meeting the estimate of -10 cents. With 2.55K shares outstanding, the current market capitalization sits at 6.52M.
A.I. Advisor
published General Information

General Information

a developer of biologic drugs, novel oncology therapeutics, and vaccinations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
945 Concord Street
Phone
+1 781 778-7720
Employees
4
Web
https://www.xeneticbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SDFSX17.150.22
+1.30%
Sit Small Cap Dividend Growth S
PHSRX58.010.55
+0.96%
Putnam Global Health Care R
TNBAX18.630.17
+0.92%
1290 SmartBeta Equity A
FTGQX26.840.15
+0.56%
Templeton Growth C
MXMVX14.25N/A
N/A
Empower Mid Cap Value Inv

XBIO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIO has been loosely correlated with ELOX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIO jumps, then ELOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIO
1D Price
Change %
XBIO100%
+1.80%
ELOX - XBIO
59%
Loosely correlated
N/A
SYRE - XBIO
34%
Loosely correlated
+4.34%
VXRT - XBIO
29%
Poorly correlated
+2.61%
EDSA - XBIO
29%
Poorly correlated
-2.52%
CDTX - XBIO
28%
Poorly correlated
-0.59%
More